SNPTECH REPORTER SUBSCRIBERS: A Lighter 800-Pound Gorilla, Applied Biosystems Takes Aim at Genotyping | GenomeWeb

Applied Biosystems has crept onto the genotyping scene with a three-pillar strategy designed to take aim at market leaders Sequenom and Illumina. But a weak tool market has wounded the sequencing giant, even forcing it to issue a terse warning to investors that deteriorating business will hamstring top-line growth for the remainder of this fiscal year. How will ABI s strategy fare? Subscribe. (https://www.snptech.com/subscribe.htmtarget=_blank)

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.